Member Info for jimbogains

Given the name of TRx’s intended partner is not mentioned, I can only assume that this is a different partner from EUDA. If so, don’t we find ourselves back where we started (ie very early days of potentially protracted negotiations with an unknown entity and which may never conclude)?

Interesting also that this has been released when it has. Val had obviously given a deadline and now they’re potentially clutching at straws.

Call me a cynic but I’m down by so much on this company now that I just can’t believe that anything will come of any of their plans.

EUDA and TheoremRx have said they will merge. TheoremRx has entered into the licence agreement regarding VAL201. However, questions abound as to whether TheoremRx has any money to pay for VAL201.

If EUDA suddenly has $100m, then this could mean that the merger and therefore VAL201 licence agreement can proceed.

Any thoughts on EUDA raising $100m?

https://www.sec.gov/Archives/edgar/data/1847846/000149315224041563/formf-3.htm

One year since TRx-EUDA merger was announced. Wonder if there's any significance to 12 months. EUDA share price has been shooting up (who knows why? expectation of a merger?) but coming down now. I wonder if the merger would have been uneconomical if the share price was too high, driven by expectation of a deal. I'm still holding out for some good news, although Val's share price is definitely painful right now.

Should definitely clarify the capital structure, assuming TRx will now get shares. That said, it’s pretty much a non-event

I assumed people were betting that they would get the deal done before the end of H1. Obviously no news last week, although they could complete over the weekend and announce tomorrow. Or not…

EUDA recently acquired two companies with the consideration wholly in the form of EUDA shares. Given that EUDA’s not exactly flush with cash, I can’t imagine the shareholders of the companies acquired would have decided to proceed if they weren’t expecting TRx cash in the very near future.

It’s coming, hopefully soon. Looking forward to multi-bagging

As with the previous RNS, i'm not entirely sure that anything has changed here. What exactly is the positive news that we didn't know already? The only one I see is that TRX-EUDA seems to be in play.

(PS curiously I did buy some shares this morning at around 1.9p before the RNS and have made a hefty profit woohoo :-) but I only did so because the fall following the last RNS was silly, as I stated at the time...)

We all understood about cash runway. The going concern statement is a requirement where continuation of the business beyond 12 months is subject to additional funding. Nothing new here, the share price drop is silly.

Sorry PM but that’s just not right. EUDA controls the subsidiary and will need to report on its consolidated position, ie in respect of the subsidiary. Anything done after the event involving the subsidiary will impact on EUDA itself.

What makes you say that, PM? Surely the idea is for TRx to get access to capital markets (listing) by merging with EUDA? If so, I would expect this to feature prominently in the forward-looking statements in the annual report

When is Val next due to give an update on the business? Can’t say it’s looking good for the TRx-EUDA merger based on lack of information in the annual report, as well as the fact that EUDA’s recent acquisitions don’t seem remotely aligned with the direction I had assumed TRx would take the combined business going forward. 201 deal has surely got to be dead in the water now?!

Looking at EUDA’s most recent filings, there seems to be no mention of TRx. Surely that deal is truly dead now

Unfortunately, I’m not sure that there’s a massive pool of competent AIM Biotech CEOs who don’t have any notice period to work and are super keen to jump on board with their seemingly failing business. There’s been lots of criticism over Suzy’s salary but were we really likely to get anyone competent on the cheap?

Nice one Badsterman. Clearly EUDA is out of cash. Why are the executives converting their debt claims in the company into shares which rank behind debts in priority on a winding up? Surely this has to mean that they think there’s upside likely to be realised in future?

Whilst I have proven time and time and time again to be excessively optimistic, maybe this heralds the good news we have been waiting for. Executives now incentivised with shares. Deal around the corner. Lots of joyous Valirx millionaires in time for Spring.

For what it’s worth, the end of today marks six months since the EUDA merger notification. Whilst highly unlikely, I’m still hopeful for an update at 9am NY time.

I like being disappointed…

Hmm have to hold my hands up, seems like I got it wrong on EUDA.

What next…

Good luck all, have a good Easter.

Porky - I was simply speculating on the reason for the EUDA share price moves last week.

Some of the EUDA loan notes convert at the end of the coming week if not settled. Share price increases are presumably due to investors thinking the TRx deal will go ahead before conversion. If it doesn’t, I’d expect a significant share price fall the following week.

Key questions for me are:

1. Does Suzy retain her share options? If so, do we risk a massive dilution if a new CEO needs more options for incentivisation?

2. Does this mean the 201 deal is dead? Seems like an odd time to give up if this completing is truly around the corner.